Mortimer, AM, Singh, P, Shepherd, CJ, Puthiryackal, J. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world. Clin Schizophr Relat Psychoses
2010; 4: 49–55.
Lieberman, JA, Kane, JM, Johns, CA. Clozapine: guidelines for clinical management. J Clin Psychiatry
1989; 50: 329–38.
National Collaborating Centre for Mental Health. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (Updated edn). National Clinical Guideline 82.
British Psychological Society and the Royal College of Psychiatrists, 2010.
Taylor, D, Paton, C, Kapur, S. The Maudsley Prescribing Guidelines (10th edn). Informa Healthcare, 2010.
Tiihonen, J, Haukka, J, Taylor, M, Haddad, PM, Patel, MX, Korhonen, P. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry
2011; 168: 603–9.
Harrison, J, Janlov, M, Wheeler, AJ. Patterns of clozapine prescribing in a mental health service in New Zealand. Pharm World Sci
2010; 32: 503–11.
Kelly, DL, Kreyenbuhl, J, Dixon, L, Love, RC, Medoff, D, Conley, RR. Clozapine underutilization and discontinuation in African Americans due to leucopenia. Schizophr Bull
2007; 33: 1221–4.
Taylor, DM, Young, C, Paton, C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. J Clin Psychiatry
2003; 64: 30–4.
Wheeler, AJ. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Ann Pharmacother
2008; 42: 852–60.
Barnes, TR. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol
2011; 25: 567–620.
National Institute for Health and Clinical Excellence. Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Clinical Guideline 1).
London: NICE, 2002.
Agid, O, Remington, G, Kapur, S, Arenovich, T, Zipursky, RB. Early use of clozapine for poorly responding first-episode psychosis. J Clin Psychopharmacol
2007; 27: 369–73.
Agid, O, Arenovich, T, Sajeev, G, Zipursky, RB, Kapur, S, Foussias, G, et al. An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis. J Clin Psychiatry
2011; 72: 1439–44.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines.
Joint Formulary Committee. British National Formulary (BNF59).
BMJ Group and Pharmaceutical Press, 2010.
Barnes, TR, Paton, C. Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs
2011; 25: 383–99.
Howes, OD, Egerton, A, Allan, V, McGuire, P, Stokes, P, Kapur, S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des
2009; 15: 2550–9.
Howes, OD, Bhatnagar, A, Gaughran, FP, Amiel, SA, Murray, RM, Pilowsky, LS. A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance. Am J Psychiatry
2004; 161: 361–3.
Howes, OD, Wheeler, MJ, Meaney, AM, O'Keane, V, Fogelman, I, Blake, G, et al. Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment. J Clin Psychopharmacol
2005; 25: 259–61.
Howes, OD, Wheeler, MJ, Pilowsky, LS, Landau, S, Murray, RM, Smith, S. Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. J Clin Psychiatry
2007; 68: 361–7.
Buchanan, RW, Kreyenbuhl, J, Kelly, DL, Noel, JM, Boggs, DL, Fischer, BA, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull
2010; 36: 71–93.
Kelly, DL, Dixon, LB, Kreyenbuhl, JA, Medoff, D, Lehman, AF, Love, RC, et al. Clozapine utilization and outcomes by race in a public mental health system: 1994-2000. J Clin Psychiatry
2006; 67: 1404–11.
Taylor, D, Shapland, L, Laverick, G, Bond, J, Munro, J. Clozapine: a survey of patient perceptions. Psychiatr Bull
2000; 24: 450–2.
Angermeyer, MC, Loffler, W, Muller, P, Schulze, B, Priebe, S. Patients‘ and relatives’ assessment of clozapine treatment. Psychol Med
2001; 31: 509–17.
Downs, J, Zinkler, M. Clozapine: national review of postcode prescribing. Psychiatr Bull
2007; 31: 384–7.
Tang, YL, Mao, PX, Jiang, F, Chen, Q, Wang, CY, Cai, ZJ, et al. Clozapine in China. Pharmacopsychiatry
2008; 41: 1–9.
Nielsen, J, Dahm, M, Lublin, H, Taylor, D. Psychiatrists' attitude towards and knowledge of clozapine treatment. J Psychopharmacol
2010; 24: 965–71.